Literature DB >> 26002266

Postinjury fibrinolysis shutdown: Rationale for selective tranexamic acid.

Ernest E Moore1, Hunter B Moore, Eduardo Gonzalez, Michael P Chapman, Kirk C Hansen, Angela Sauaia, Christopher C Silliman, Anirban Banerjee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26002266      PMCID： PMC4443855          DOI： 10.1097/TA.0000000000000634

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN： 2163-0755            Impact factor:   3.313


× No keyword cloud information.
  33 in total

1.  Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study.

Authors:  Jonathan J Morrison; Joseph J Dubose; Todd E Rasmussen; Mark J Midwinter
Journal:  Arch Surg       Date:  2011-10-17

2.  Do all trauma patients benefit from tranexamic acid?

Authors:  Evan J Valle; Casey J Allen; Robert M Van Haren; Jassin M Jouria; Hua Li; Alan S Livingstone; Nicholas Namias; Carl I Schulman; Kenneth G Proctor
Journal:  J Trauma Acute Care Surg       Date:  2014-06       Impact factor: 3.313

3.  Fast interpretation of thromboelastometry in non-cardiac surgery: reliability in patients with hypo-, normo-, and hypercoagulability.

Authors:  K Görlinger; D Dirkmann; C Solomon; A A Hanke
Journal:  Br J Anaesth       Date:  2012-10-30       Impact factor: 9.166

4.  Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma.

Authors:  Jeffry L Kashuk; Ernest E Moore; Michael Sawyer; Max Wohlauer; Michael Pezold; Carlton Barnett; Walter L Biffl; Clay C Burlew; Jeffrey L Johnson; Angela Sauaia
Journal:  Ann Surg       Date:  2010-09       Impact factor: 12.969

5.  The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.

Authors:  Ian Roberts; Haleema Shakur; Adefemi Afolabi; Karim Brohi; Tim Coats; Yashbir Dewan; Satoshi Gando; Gordon Guyatt; B J Hunt; Carlos Morales; Pablo Perel; David Prieto-Merino; Tom Woolley
Journal:  Lancet       Date:  2011-03-26       Impact factor: 79.321

Review 6.  Tranexamic acid and trauma: current status and knowledge gaps with recommended research priorities.

Authors:  Anthony E Pusateri; Richard B Weiskopf; Vikhyat Bebarta; Frank Butler; Ramon F Cestero; Irshad H Chaudry; Virgil Deal; Warren C Dorlac; Robert T Gerhardt; Michael B Given; Dan R Hansen; W Keith Hoots; Harvey G Klein; Victor W Macdonald; Kenneth L Mattox; Rodney A Michael; Jon Mogford; Elizabeth A Montcalm-Smith; Debra M Niemeyer; W Keith Prusaczyk; Joseph F Rappold; Todd Rassmussen; Francisco Rentas; James Ross; Christopher Thompson; Leo D Tucker
Journal:  Shock       Date:  2013-02       Impact factor: 3.454

7.  Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration.

Authors:  Bryan A Cotton; John A Harvin; Vadim Kostousouv; Kristin M Minei; Zayde A Radwan; Herbert Schöchl; Charles E Wade; John B Holcomb; Nena Matijevic
Journal:  J Trauma Acute Care Surg       Date:  2012-08       Impact factor: 3.313

8.  A principal component analysis of postinjury viscoelastic assays: clotting factor depletion versus fibrinolysis.

Authors:  Theresa L Chin; Ernest E Moore; Hunter B Moore; Eduardo Gonzalez; Michael P Chapman; John R Stringham; Christopher R Ramos; Anirban Banerjee; Angela Sauaia
Journal:  Surgery       Date:  2014-06-21       Impact factor: 3.982

9.  Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy.

Authors:  Hunter B Moore; Ernest E Moore; Eduardo Gonzalez; Michael P Chapman; Theresa L Chin; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2014-12       Impact factor: 3.313

10.  A principal component analysis of coagulation after trauma.

Authors:  Matthew E Kutcher; Adam R Ferguson; Mitchell J Cohen
Journal:  J Trauma Acute Care Surg       Date:  2013-05       Impact factor: 3.313
View more
  23 in total

1.  [Uncritical use of tranexamic acid in trauma patients : Do no further harm!]

Authors:  M Maegele
Journal:  Unfallchirurg       Date:  2016-11       Impact factor: 1.000

2.  Redefining postinjury fibrinolysis phenotypes using two viscoelastic assays.

Authors:  Gregory R Stettler; Ernest E Moore; Hunter B Moore; Geoffrey R Nunns; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2019-04       Impact factor: 3.313

Review 3.  Antifibrinolytic Therapy and Perioperative Considerations.

Authors:  Jerrold H Levy; Andreas Koster; Quintin J Quinones; Truman J Milling; Nigel S Key
Journal:  Anesthesiology       Date:  2018-03       Impact factor: 7.892

Review 4.  β-Blockade use for Traumatic Injuries and Immunomodulation: A Review of Proposed Mechanisms and Clinical Evidence.

Authors:  Tyler J Loftus; Philip A Efron; Lyle L Moldawer; Alicia M Mohr
Journal:  Shock       Date:  2016-10       Impact factor: 3.454

Review 5.  Tranexamic Acid Use in Prehospital Uncontrolled Hemorrhage.

Authors:  Benjamin R Huebner; Warren C Dorlac; Chris Cribari
Journal:  Wilderness Environ Med       Date:  2017-06       Impact factor: 1.518

6.  A combat casualty relevant dismounted complex blast injury model in swine.

Authors:  Alexis L Cralley; Ernest E Moore; Daniel Kissau; Julia R Coleman; Navin Vigneshwar; Margot DeBot; Terry R Schaid; Hunter B Moore; Mitchell J Cohen; Kirk Hansen; Christopher C Silliman; Angela Sauaia; Charles J Fox
Journal:  J Trauma Acute Care Surg       Date:  2022-05-12       Impact factor: 3.697

7.  Efficacy of Chitosan-Based Dressing for Control of Bleeding in Excisional Wounds.

Authors:  Anne-Heloise Stricker-Krongrad; Zahra Alikhassy; Nicolette Matsangos; Raul Sebastian; Guy Marti; Frank Lay; John W Harmon
Journal:  Eplasty       Date:  2018-03-10

8.  Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT.

Authors:  Ian Roberts; Haleema Shakur-Still; Amy Aeron-Thomas; Danielle Beaumont; Antonio Belli; Amy Brenner; Madeleine Cargill; Rizwana Chaudhri; Nicolas Douglas; Lauren Frimley; Catherine Gilliam; Amber Geer; Zahra Jamal; Rashid Jooma; Raoul Mansukhani; Alec Miners; Jason Pott; Danielle Prowse; Temitayo Shokunbi; Jack Williams
Journal:  Health Technol Assess       Date:  2021-04       Impact factor: 4.014

9.  28-day thawed plasma maintains α2 -antiplasmin levels and inhibits tPA-induced fibrinolysis.

Authors:  Gregory R Stettler; Ernest E Moore; Benjamin R Huebner; Geoffrey R Nunns; Hunter B Moore; Julia R Coleman; Marguerite Kelher; Anirban Banerjee; Christopher C Silliman
Journal:  Vox Sang       Date:  2020-09-07       Impact factor: 2.144

10.  Modern Management of Bleeding, Clotting, and Coagulopathy in Trauma Patients: What Is the Role of Viscoelastic Assays?

Authors:  Sanjeev Dhara; Ernest E Moore; Michael B Yaffe; Hunter B Moore; Christopher D Barrett
Journal:  Curr Trauma Rep       Date:  2020-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.